Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Aug 2026 for Relay Therapeutics, Inc., €718k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sekar Kathiresan: trading record in brief
Sekar Kathiresan is a declared insider of Relay Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 20 July 2026 to 4 August 2026, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 4 August 2026, reports a transaction of €718k in Relay Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sekar Kathiresan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
42,225 shares@ US$19.5729CommonSEC144:0001950047-26-007601
30,000 shares@ US$18.78510.014% mcap22.9% of flowCommonSEC144:0001950047-26-007457
30,000 shares@ US$19.81380.014% mcap31.5% of flowCommonSEC144:0001950047-26-007243
66,055 shares@ US$19.5830.030% mcap100.0% of flowCommonSEC144:0001950047-26-007212
4 of 4 declarations
